首页 > 最新文献

Ai zheng = Aizheng = Chinese journal of cancer最新文献

英文 中文
[Epidemiologic trend of and strategies for colorectal cancer]. 【结直肠癌流行趋势及防治对策】。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10833
De-Sen Wan

The incidence and mortality of colorectal cancer (CRC) show increasing tendency worldwide. It was predicted that the new cases in 2007 would be approximate 1,200,000 and the death cases would be 630,000, a total increase of 27% and 28% and an annual increase of 3.9% and 4.0%, respectively, compared with the figures in 2000. In addition, the incidence of CRC varies regionally and changes over the time. In previously identified high-incidence areas, there are three tendencies: one is to keep rising such as in UK, one is to be stable such as in New Zealand, and the third one is to decrease such as in US and Western Europe. In previously identified low-incidence areas, the incidence of CRC is increasing, such as in Japan, Hong Kong, Singapore, Hungary, Poland, Israel, and Puerto-Rico, especially in Japan, where the incidence increases the fastest. Similarly, the incidence of CRC is increased by 4.2% annually in Shanghai, China, which is faster than the average increasing rate of the world. Since 1991, the average increase in mortality of CRC is 4.7% every year. The increasing number of female patients and the shift of the tumor location to the right side are also noticed for CRC in recent years. We summarized that CRC is a disease caused by synergism of environment and diet, life style and heredity. It was suggested that CRC can be prevented effectively through developing a regular life style, having proper diet, actively participating in the screening for cancers, and removing the pre-cancer lesions.

结直肠癌(CRC)的发病率和死亡率在世界范围内呈上升趋势。据预测,2007年新增病例约为120万例,死亡病例约为63万例,与2000年的数字相比,分别增加27%和28%,年增长率分别为3.9%和4.0%。此外,结直肠癌的发病率因地区而异,随时间而变化。在以前确定的高发地区,有三种趋势:一是持续上升,如英国;二是稳定,如新西兰;三是下降,如美国和西欧。在以前确定的低发病率地区,CRC的发病率正在增加,如日本、香港、新加坡、匈牙利、波兰、以色列和波多黎各,特别是在发病率增长最快的日本。同样,中国上海的CRC发病率以每年4.2%的速度增长,高于世界平均增长速度。自1991年以来,结直肠癌的死亡率平均每年增加4.7%。近年来,女性患者数量的增加和肿瘤位置向右侧的转移也引起了CRC的注意。综上所述,结直肠癌是一种环境与饮食、生活方式和遗传共同作用的疾病。建议通过养成规律的生活方式,合理饮食,积极参与癌症筛查,切除癌前病变,可以有效预防结直肠癌。
{"title":"[Epidemiologic trend of and strategies for colorectal cancer].","authors":"De-Sen Wan","doi":"10.5732/cjc.008.10833","DOIUrl":"https://doi.org/10.5732/cjc.008.10833","url":null,"abstract":"<p><p>The incidence and mortality of colorectal cancer (CRC) show increasing tendency worldwide. It was predicted that the new cases in 2007 would be approximate 1,200,000 and the death cases would be 630,000, a total increase of 27% and 28% and an annual increase of 3.9% and 4.0%, respectively, compared with the figures in 2000. In addition, the incidence of CRC varies regionally and changes over the time. In previously identified high-incidence areas, there are three tendencies: one is to keep rising such as in UK, one is to be stable such as in New Zealand, and the third one is to decrease such as in US and Western Europe. In previously identified low-incidence areas, the incidence of CRC is increasing, such as in Japan, Hong Kong, Singapore, Hungary, Poland, Israel, and Puerto-Rico, especially in Japan, where the incidence increases the fastest. Similarly, the incidence of CRC is increased by 4.2% annually in Shanghai, China, which is faster than the average increasing rate of the world. Since 1991, the average increase in mortality of CRC is 4.7% every year. The increasing number of female patients and the shift of the tumor location to the right side are also noticed for CRC in recent years. We summarized that CRC is a disease caused by synergism of environment and diet, life style and heredity. It was suggested that CRC can be prevented effectively through developing a regular life style, having proper diet, actively participating in the screening for cancers, and removing the pre-cancer lesions.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"897-902"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28379584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
[Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer]. [局部晚期直肠癌新辅助治疗后淋巴结转移相关危险因素]。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10806
Zhi-Fan Zeng, Pei-Rong Ding, Zhi-Zhong Pan, Jun-Zhong Lin, Li-Ren Li, Zhen-Hai Lu, Xiao-Jun Wu, Ling-Heng Kong, Zhong-Guo Zhou, De-Sen Wan

Background and objective: Neoadjuvant therapy (radiotherapy, RT or chemoradiotherapy, CRT) could change status of the invasion and lymph node metastasis of rectal cancer. The risk factors of lymph node metastasis in rectal cancers without neoadjuvant therapy have been well known, but those in rectal cancers treated with preoperative RT or CRT remain unclear. This study was to investigate the risk factors of lymph node metastasis in patients who underwent preoperative RT or CRT for rectal cancers.

Methods: Clinical data of 93 patients underwent preoperative RT or CRT followed by total mesorectal exesion (TME) for locally advanced rectal adenocarcinoma from August, 2003 to February, 2008 were reviewed. Twelve clinicopathologic factors and treatment-related factors were studied with univariate and multivariate analyses.

Results: Univariate analysis showed that post-RT or post-CRT serum carcinoembryonic antigen (CEA) level, radiation dose, time interval from RT or CRT to TME, concurrent chemotherapy with oxaliplatin-containing regimens, and infiltration extent to bowel wall after RT or CRT (ypT stage) were significantly associated with lymph node status after RT or CRT (ypN stage). Multivariate analysis showed that concurrent chemotherapy with oxaliplatin-containing regimens (r=-0.481, P<0.01) and ypT stage (r=0.503, P<0.01) were independent risk factors of ypN stage.

Conclusions: Pathologic T stage is the most reliable predictor of lymph node stage in rectal cancer patients received preoperative RT or CRT. Oxaliplatin-containing regimens could significantly reduce the risks of lymph node metastases and potentially improve the prognosis.

背景与目的:新辅助治疗(放疗,RT或放化疗,CRT)可以改变直肠癌的侵袭和淋巴结转移状况。未经新辅助治疗的直肠癌发生淋巴结转移的危险因素已经众所周知,但术前接受RT或CRT治疗的直肠癌发生淋巴结转移的危险因素尚不清楚。本研究旨在探讨直肠癌术前放疗或CRT患者淋巴结转移的危险因素。方法:回顾性分析2003年8月至2008年2月93例局部进展期直肠腺癌术前行RT或CRT后全肠系膜切除术(TME)的临床资料。采用单因素和多因素分析对12个临床病理因素和治疗相关因素进行研究。结果:单因素分析显示,放疗后或CRT后血清癌胚抗原(CEA)水平、放疗剂量、放疗或CRT至TME的时间间隔、同时使用含奥沙利铂的化疗方案、放疗或CRT后肠壁浸润程度(ypN期)与放疗或CRT后淋巴结状态(ypN期)显著相关。多因素分析显示,与含奥沙利铂方案同期化疗(r=-0.481, p)。结论:病理T分期是术前接受RT或CRT的直肠癌患者淋巴结分期最可靠的预测指标。含奥沙利铂方案可以显著降低淋巴结转移的风险,并可能改善预后。
{"title":"[Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].","authors":"Zhi-Fan Zeng,&nbsp;Pei-Rong Ding,&nbsp;Zhi-Zhong Pan,&nbsp;Jun-Zhong Lin,&nbsp;Li-Ren Li,&nbsp;Zhen-Hai Lu,&nbsp;Xiao-Jun Wu,&nbsp;Ling-Heng Kong,&nbsp;Zhong-Guo Zhou,&nbsp;De-Sen Wan","doi":"10.5732/cjc.008.10806","DOIUrl":"https://doi.org/10.5732/cjc.008.10806","url":null,"abstract":"<p><strong>Background and objective: </strong>Neoadjuvant therapy (radiotherapy, RT or chemoradiotherapy, CRT) could change status of the invasion and lymph node metastasis of rectal cancer. The risk factors of lymph node metastasis in rectal cancers without neoadjuvant therapy have been well known, but those in rectal cancers treated with preoperative RT or CRT remain unclear. This study was to investigate the risk factors of lymph node metastasis in patients who underwent preoperative RT or CRT for rectal cancers.</p><p><strong>Methods: </strong>Clinical data of 93 patients underwent preoperative RT or CRT followed by total mesorectal exesion (TME) for locally advanced rectal adenocarcinoma from August, 2003 to February, 2008 were reviewed. Twelve clinicopathologic factors and treatment-related factors were studied with univariate and multivariate analyses.</p><p><strong>Results: </strong>Univariate analysis showed that post-RT or post-CRT serum carcinoembryonic antigen (CEA) level, radiation dose, time interval from RT or CRT to TME, concurrent chemotherapy with oxaliplatin-containing regimens, and infiltration extent to bowel wall after RT or CRT (ypT stage) were significantly associated with lymph node status after RT or CRT (ypN stage). Multivariate analysis showed that concurrent chemotherapy with oxaliplatin-containing regimens (r=-0.481, P<0.01) and ypT stage (r=0.503, P<0.01) were independent risk factors of ypN stage.</p><p><strong>Conclusions: </strong>Pathologic T stage is the most reliable predictor of lymph node stage in rectal cancer patients received preoperative RT or CRT. Oxaliplatin-containing regimens could significantly reduce the risks of lymph node metastases and potentially improve the prognosis.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"923-7"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28379589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effects of energy controllable steep pulses on intracellular calcium concentration and cell membrane potential]. [能量可控陡脉冲对细胞内钙浓度和细胞膜电位的影响]。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10614
Xiao-Jing Dong, Li-Na Hu, Yun-Shan Zhu, Chuan Hong, Cong Li, Xiao-Dong Luo

Background and objective: Our previous experiments showed that steep pulses could kill tumor cells, but the mechanism is unclear. This study was to probe the effects of different dosages of energy controllable steep pulses (ECSP) on intracellular concentration of dissociative calcium ion ([Ca2+]i) and cell membrane potential.

Methods: The breast carcinoma MDA-MB-231 cells were divided into control group and five ECSP (different dosages) groups. Ca2+ was labeled by Fluo-3/AM and cell membrane potential was labeled by DiBAC4(3). The mean fluorescence intensity in MDA-MB-231 cells was observed by laser confocal microscopy after ECSP treatment. The changes of calcium concentration and cell membrane potential after ECSP treatment were analyzed. The changes of intracellular [Ca2+]i after ECSP treatment were also observed either with or without Ca2+ outside of the cells.

Results: Ca2+ outflow was observed when the cells were treated with lower dosage of pulse in quiet state; the outflow was enhanced with the dosage increase. In real-time kinetic detection, intracellular Ca2+ concentration was increased with the increase of pulse electric field intensity when cells were treated with lower dosages of ECSP. When the voltage was 285 V, frequency was 100 Hz, [Ca2+]i decreased obviously. The intracellular Ca2+ concentration was obviously lower in the cells without outside Ca2+ than in cells with outside Ca2+, but it still increased gradually. Low dosage of ECSP induced the increase of cell membrane potential, indicating the depolarization of cell membrane. With increase of the dosage, cell membrane potential was attenuated, indicating the superpolarization of cell membrane.

Conclusion: Lower dosage of ECSP can induce the depolarization of cell membrane and the inflow of outside Ca2+; higher dosage of ECSP can directly destroy the cell membrane and induce the superpolarization of cell membrane, then induce the outflow of intracellular Ca2+ which causes the necrosis of tumor cells.

背景与目的:我们之前的实验表明,陡脉冲可以杀死肿瘤细胞,但其作用机制尚不清楚。本研究旨在探讨不同剂量能量可控陡脉冲(ECSP)对胞内解离性钙离子([Ca2+]i)浓度和细胞膜电位的影响。方法:将乳腺癌MDA-MB-231细胞分为对照组和5个不同剂量的ECSP组。用Fluo-3/AM标记Ca2+,用DiBAC4标记细胞膜电位(3)。用激光共聚焦显微镜观察经ECSP处理后MDA-MB-231细胞的平均荧光强度。分析了ECSP处理后钙浓度和细胞膜电位的变化。在细胞外有或没有Ca2+的情况下,观察ECSP处理后细胞内[Ca2+]i的变化。结果:静态下低剂量脉冲作用时,细胞有Ca2+流出;流出量随剂量的增加而增强。在实时动力学检测中,低剂量ECSP处理细胞时,细胞内Ca2+浓度随脉冲电场强度的增加而增加。当电压为285 V,频率为100 Hz时,[Ca2+]i明显降低。细胞内Ca2+浓度在无外部Ca2+的细胞中明显低于有外部Ca2+的细胞,但仍在逐渐升高。低剂量ECSP诱导细胞膜电位升高,表明细胞膜去极化。随着剂量的增加,细胞膜电位减弱,表明细胞膜发生超极化。结论:小剂量的ECSP可诱导细胞膜去极化和体外Ca2+的流入;较高剂量的ECSP可直接破坏细胞膜,诱导细胞膜超极化,进而诱导细胞内Ca2+外流,引起肿瘤细胞坏死。
{"title":"[Effects of energy controllable steep pulses on intracellular calcium concentration and cell membrane potential].","authors":"Xiao-Jing Dong,&nbsp;Li-Na Hu,&nbsp;Yun-Shan Zhu,&nbsp;Chuan Hong,&nbsp;Cong Li,&nbsp;Xiao-Dong Luo","doi":"10.5732/cjc.008.10614","DOIUrl":"https://doi.org/10.5732/cjc.008.10614","url":null,"abstract":"<p><strong>Background and objective: </strong>Our previous experiments showed that steep pulses could kill tumor cells, but the mechanism is unclear. This study was to probe the effects of different dosages of energy controllable steep pulses (ECSP) on intracellular concentration of dissociative calcium ion ([Ca2+]i) and cell membrane potential.</p><p><strong>Methods: </strong>The breast carcinoma MDA-MB-231 cells were divided into control group and five ECSP (different dosages) groups. Ca2+ was labeled by Fluo-3/AM and cell membrane potential was labeled by DiBAC4(3). The mean fluorescence intensity in MDA-MB-231 cells was observed by laser confocal microscopy after ECSP treatment. The changes of calcium concentration and cell membrane potential after ECSP treatment were analyzed. The changes of intracellular [Ca2+]i after ECSP treatment were also observed either with or without Ca2+ outside of the cells.</p><p><strong>Results: </strong>Ca2+ outflow was observed when the cells were treated with lower dosage of pulse in quiet state; the outflow was enhanced with the dosage increase. In real-time kinetic detection, intracellular Ca2+ concentration was increased with the increase of pulse electric field intensity when cells were treated with lower dosages of ECSP. When the voltage was 285 V, frequency was 100 Hz, [Ca2+]i decreased obviously. The intracellular Ca2+ concentration was obviously lower in the cells without outside Ca2+ than in cells with outside Ca2+, but it still increased gradually. Low dosage of ECSP induced the increase of cell membrane potential, indicating the depolarization of cell membrane. With increase of the dosage, cell membrane potential was attenuated, indicating the superpolarization of cell membrane.</p><p><strong>Conclusion: </strong>Lower dosage of ECSP can induce the depolarization of cell membrane and the inflow of outside Ca2+; higher dosage of ECSP can directly destroy the cell membrane and induce the superpolarization of cell membrane, then induce the outflow of intracellular Ca2+ which causes the necrosis of tumor cells.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"961-6"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28382057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Correlation of multi-slice spiral CT features to clinicopathologic manifestations of gastrointestinal stromal tumor: a report of 49 cases]. 【附49例胃肠道间质瘤临床病理表现与多层螺旋CT表现的关系】。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10832
Shao-Han Yin, Chuan-Miao Xie, Yun-Xian Mo, Zi-Lin Huang, Yan-Chun Lu, Xue-Wen Liu, Yun Zhang, Jian-Peng Li, Lie Zheng, Pei-Hong Wu

Background and objective: Gastrointestinal stromal tumor (GIST) is one of the most common mesenchymal tumors of the digestive system. Imaging examination plays an important role in preoperative diagnosis and postoperative evaluation for it. This study was to describe the multi-slice spiral computed tomographic (MSCT) findings and pathologic features of GIST, and to analyze their correlation.

Methods: MSCT and pathologic reports of 49 patients with 53 pathologically confirmed GIST lesions were reviewed and compared.

Results: Of the 53 GIST lesions, 14 were at very low biological risk, 11 at low risk, ten at moderate risk and 18 at high risk; 36 (67.9%) were found in first visit by CT scans. On CT images, the GIST lesions with maximal diameter of > or =50 mm showed irregular shape, invasive growth, presence of cystic area and heterogeneous enhancement, and most of them were at high risk; the lesions with maximal diameter of <50 mm showed regular shape, expansive growth, and homogeneous enhancement, and most of them were at risk of moderate or below. No lymph node metastasis was found. Only three lesions showed S100-positive, which presented infiltration along the gastric wall or bowel ring on CT images.

Conclusions: CT examination is helpful in risk prediction for GIST, but it is difficult to detect small lesions (< 2 cm) by CT scans. Due to the infiltrative growth of GIST with neural differentiation (S100-positive), it is difficult to distinguish GIST from gastric cancer on CT images.

背景与目的:胃肠道间质瘤(GIST)是最常见的消化系统间质肿瘤之一。影像学检查在术前诊断和术后评价中具有重要作用。本研究旨在描述胃肠道间质瘤的多层螺旋ct (MSCT)表现与病理特征,并分析其相关性。方法:对49例经病理证实的间质间质瘤病变的MSCT和病理报告进行回顾性分析和比较。结果:53例GIST病变中,极低生物学风险14例,低风险11例,中度风险10例,高风险18例;首次CT扫描发现36例(67.9%)。最大直径>或=50 mm的GIST病变在CT上表现为形状不规则、浸润性生长、囊性区存在、不均匀强化,多为高危病变;结论:CT检查有助于预测GIST的风险,但CT扫描难以发现小于2 cm的小病变。由于GIST具有神经分化的浸润性生长(s100阳性),在CT图像上难以与胃癌区分。
{"title":"[Correlation of multi-slice spiral CT features to clinicopathologic manifestations of gastrointestinal stromal tumor: a report of 49 cases].","authors":"Shao-Han Yin,&nbsp;Chuan-Miao Xie,&nbsp;Yun-Xian Mo,&nbsp;Zi-Lin Huang,&nbsp;Yan-Chun Lu,&nbsp;Xue-Wen Liu,&nbsp;Yun Zhang,&nbsp;Jian-Peng Li,&nbsp;Lie Zheng,&nbsp;Pei-Hong Wu","doi":"10.5732/cjc.008.10832","DOIUrl":"https://doi.org/10.5732/cjc.008.10832","url":null,"abstract":"<p><strong>Background and objective: </strong>Gastrointestinal stromal tumor (GIST) is one of the most common mesenchymal tumors of the digestive system. Imaging examination plays an important role in preoperative diagnosis and postoperative evaluation for it. This study was to describe the multi-slice spiral computed tomographic (MSCT) findings and pathologic features of GIST, and to analyze their correlation.</p><p><strong>Methods: </strong>MSCT and pathologic reports of 49 patients with 53 pathologically confirmed GIST lesions were reviewed and compared.</p><p><strong>Results: </strong>Of the 53 GIST lesions, 14 were at very low biological risk, 11 at low risk, ten at moderate risk and 18 at high risk; 36 (67.9%) were found in first visit by CT scans. On CT images, the GIST lesions with maximal diameter of > or =50 mm showed irregular shape, invasive growth, presence of cystic area and heterogeneous enhancement, and most of them were at high risk; the lesions with maximal diameter of <50 mm showed regular shape, expansive growth, and homogeneous enhancement, and most of them were at risk of moderate or below. No lymph node metastasis was found. Only three lesions showed S100-positive, which presented infiltration along the gastric wall or bowel ring on CT images.</p><p><strong>Conclusions: </strong>CT examination is helpful in risk prediction for GIST, but it is difficult to detect small lesions (< 2 cm) by CT scans. Due to the infiltrative growth of GIST with neural differentiation (S100-positive), it is difficult to distinguish GIST from gastric cancer on CT images.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"983-8"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28382598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
[Prognosis of rectal cancer patients after total mesorectal excision]. 【直肠癌患者全肠系膜切除后的预后分析】。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10804
Zhi-Zhong Pan, Pei-Rong Ding, De-Sen Wan, Li-Ren Li, Xiao-Jun Wu, Zhen-Hai Lu, Ling-Heng Kong, Jun-Zhong Lin, Zhong-Guo Zhou

Background and objective: Total mesorectal excision (TME) can reduce local recurrence and improve prognosis of rectal cancer. This study was to analyze the clinicopathologic characteristics of rectal cancer, and explore the prognosis factors of rectal cancer after radical TME.

Methods: From 1990 to 2003, 1056 rectal cancer patients had received radical TME. The impacts of 20 clinicopathologic factors on the prognosis were analyzed with univariate and multivariate method.

Results: The 3-, 5-, and 10-year overall survival rates were 84.9% (95% CI, 83.8%-86.0%), 73.8% (95% CI, 72.4%-75.2%), and 65.1% (95% CI, 63.4%-66.8%), respectively. Univariate analysis showed that preoperative serum carcinoembryonic antigen (CEA) and CA19-9 levels, tumor gross type, pathologic type, pathologic grade, preoperative bowel obstruction or bowel perforation, T stage, N stage, and first treatment era were associated with the prognosis of rectal cancer. Multivariate analysis showed that N stage, histological type, surgical procedures, and T stage were independent prognostic factors.

Conclusion: N stage, histological type, surgical procedures, and T stage are independent prognostic factors for rectal cancer patients who received radical TME.

背景与目的:直肠癌全肠系膜切除术(TME)可减少局部复发,改善预后。本研究旨在分析直肠癌的临床病理特点,探讨根治性TME后直肠癌的预后因素。方法:1990 ~ 2003年,1056例直肠癌患者行根治性TME治疗。采用单因素和多因素分析20种临床病理因素对预后的影响。结果:3年、5年和10年总生存率分别为84.9% (95% CI, 83.8%-86.0%)、73.8% (95% CI, 72.4%-75.2%)和65.1% (95% CI, 63.4%-66.8%)。单因素分析显示,术前血清癌胚抗原(CEA)、CA19-9水平、肿瘤大体类型、病理类型、病理分级、术前肠梗阻或肠穿孔、T分期、N分期、首次治疗时间与直肠癌预后相关。多因素分析显示,N分期、组织学类型、手术方式和T分期是独立的预后因素。结论:N分期、组织学类型、手术方式、T分期是直肠癌根治性TME患者预后的独立影响因素。
{"title":"[Prognosis of rectal cancer patients after total mesorectal excision].","authors":"Zhi-Zhong Pan,&nbsp;Pei-Rong Ding,&nbsp;De-Sen Wan,&nbsp;Li-Ren Li,&nbsp;Xiao-Jun Wu,&nbsp;Zhen-Hai Lu,&nbsp;Ling-Heng Kong,&nbsp;Jun-Zhong Lin,&nbsp;Zhong-Guo Zhou","doi":"10.5732/cjc.008.10804","DOIUrl":"https://doi.org/10.5732/cjc.008.10804","url":null,"abstract":"<p><strong>Background and objective: </strong>Total mesorectal excision (TME) can reduce local recurrence and improve prognosis of rectal cancer. This study was to analyze the clinicopathologic characteristics of rectal cancer, and explore the prognosis factors of rectal cancer after radical TME.</p><p><strong>Methods: </strong>From 1990 to 2003, 1056 rectal cancer patients had received radical TME. The impacts of 20 clinicopathologic factors on the prognosis were analyzed with univariate and multivariate method.</p><p><strong>Results: </strong>The 3-, 5-, and 10-year overall survival rates were 84.9% (95% CI, 83.8%-86.0%), 73.8% (95% CI, 72.4%-75.2%), and 65.1% (95% CI, 63.4%-66.8%), respectively. Univariate analysis showed that preoperative serum carcinoembryonic antigen (CEA) and CA19-9 levels, tumor gross type, pathologic type, pathologic grade, preoperative bowel obstruction or bowel perforation, T stage, N stage, and first treatment era were associated with the prognosis of rectal cancer. Multivariate analysis showed that N stage, histological type, surgical procedures, and T stage were independent prognostic factors.</p><p><strong>Conclusion: </strong>N stage, histological type, surgical procedures, and T stage are independent prognostic factors for rectal cancer patients who received radical TME.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"903-7"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28379585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up]. [18F-FDG PET/CT在随访期间血清鳞状细胞癌抗原升高的宫颈癌中的应用]。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.009.10097
Ying-Ying Hu, Xin-Ru Sun, Xiao-Ping Lin, Pei-Yan Liang, Xu Zhang, Wei Fan

Background and objective: Accurate and early diagnosis of recurrence for cervical cancer after the treatment and aggressive salvage treatment could improve the prognosis of this disease. Serum squamous cell carcinoma antigen (SCCAg) is the most commonly used tumor marker for the detection of asymptomatic recurrence of cervical cancer. This study was to evaluate the application and value of (18)F-FDG PET/CT in cervical cancer with elevated of serum SCCAg level during the follow-up.

Methods: Thirty-one patients with cervical cancer with elevated serum SCCAg level during the follow-up undergoing (18)F-FDG PET/CT in Sun Yat-sen University Cancer Center between August 2005 and November 2008 were entered into this retrospective study. The pathological types, the serum SCCAg level, PET/CT results, results of other imaging modalities, pathological and clinical follow-ups were recorded.

Results: All 31 patients'pathological examination showed squamous cell carcinoma, including three adenosquamous carcinoma. Lesions of all patients were examined by PET/CT. Three patients had local recurrence in the uterus or vagina, 28 had metastatic disease. Of these 31 patients, three were confirmed to have local recurrent disease, 27 were verified to have metastatic disease and one was diagnosed as primary lung squamous cell carcinoma by pathological or clinical manifestations. The total detection rate of PET/CT for malignancy was 100% (31/31); the diagnostic accuracy of PET/CT for recurrent cervical cancer was 96.8% (30/31). The levels of serum SCCAg during the follow-up were 1.5-37.8 ng/ml. There was no relation between the level of serum SCCAg and the maximum standard uptake value (SUVmax) of PET/CT. Compared with other imaging modalities, PET/CT was more efficient in detecting recurrence and finding more lesions.

Conclusions: An elevated level of SCCAg in cervical cancer during the follow-up indicates tumor recurrence. PET/CT is efficient in detecting the recurrence and has high diagnostic accuracy.

背景与目的:准确、早期诊断宫颈癌治疗后复发及积极的抢救治疗可改善该病的预后。血清鳞状细胞癌抗原(SCCAg)是检测宫颈癌无症状复发最常用的肿瘤标志物。本研究旨在评价(18)F-FDG PET/CT在随访期间血清SCCAg水平升高的宫颈癌中的应用及价值。方法:选取2005年8月至2008年11月中山大学肿瘤中心行(18)F-FDG PET/CT随访时血清SCCAg水平升高的宫颈癌患者31例进行回顾性研究。记录病理分型、血清SCCAg水平、PET/CT及其他影像学检查结果、病理及临床随访情况。结果:31例患者病理检查均为鳞状细胞癌,其中腺鳞癌3例。所有患者均行PET/CT检查病变。子宫或阴道局部复发3例,转移性疾病28例。31例患者中3例确诊为局部复发,27例确诊为转移性疾病,1例经病理或临床表现诊断为原发性肺鳞状细胞癌。PET/CT对恶性肿瘤的总检出率为100% (31/31);PET/CT对复发性宫颈癌的诊断准确率为96.8%(30/31)。随访期间血清SCCAg水平为1.5 ~ 37.8 ng/ml。血清SCCAg水平与PET/CT最大标准摄取值(SUVmax)无相关性。与其他成像方式相比,PET/CT在发现复发和发现更多病变方面更有效。结论:随访期间宫颈SCCAg水平升高提示肿瘤复发。PET/CT检测复发率高,诊断准确率高。
{"title":"[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].","authors":"Ying-Ying Hu,&nbsp;Xin-Ru Sun,&nbsp;Xiao-Ping Lin,&nbsp;Pei-Yan Liang,&nbsp;Xu Zhang,&nbsp;Wei Fan","doi":"10.5732/cjc.009.10097","DOIUrl":"https://doi.org/10.5732/cjc.009.10097","url":null,"abstract":"<p><strong>Background and objective: </strong>Accurate and early diagnosis of recurrence for cervical cancer after the treatment and aggressive salvage treatment could improve the prognosis of this disease. Serum squamous cell carcinoma antigen (SCCAg) is the most commonly used tumor marker for the detection of asymptomatic recurrence of cervical cancer. This study was to evaluate the application and value of (18)F-FDG PET/CT in cervical cancer with elevated of serum SCCAg level during the follow-up.</p><p><strong>Methods: </strong>Thirty-one patients with cervical cancer with elevated serum SCCAg level during the follow-up undergoing (18)F-FDG PET/CT in Sun Yat-sen University Cancer Center between August 2005 and November 2008 were entered into this retrospective study. The pathological types, the serum SCCAg level, PET/CT results, results of other imaging modalities, pathological and clinical follow-ups were recorded.</p><p><strong>Results: </strong>All 31 patients'pathological examination showed squamous cell carcinoma, including three adenosquamous carcinoma. Lesions of all patients were examined by PET/CT. Three patients had local recurrence in the uterus or vagina, 28 had metastatic disease. Of these 31 patients, three were confirmed to have local recurrent disease, 27 were verified to have metastatic disease and one was diagnosed as primary lung squamous cell carcinoma by pathological or clinical manifestations. The total detection rate of PET/CT for malignancy was 100% (31/31); the diagnostic accuracy of PET/CT for recurrent cervical cancer was 96.8% (30/31). The levels of serum SCCAg during the follow-up were 1.5-37.8 ng/ml. There was no relation between the level of serum SCCAg and the maximum standard uptake value (SUVmax) of PET/CT. Compared with other imaging modalities, PET/CT was more efficient in detecting recurrence and finding more lesions.</p><p><strong>Conclusions: </strong>An elevated level of SCCAg in cervical cancer during the follow-up indicates tumor recurrence. PET/CT is efficient in detecting the recurrence and has high diagnostic accuracy.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"994-9"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28382600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
[Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma]. [直肠腺癌术前放疗后病理完全缓解相关临床病理因素的多因素分析]。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10808
Jun-Zhong Lin, Zhi-Zhong Pan, Zhi-Fan Zeng, Pei-Rong Ding, De-Sen Wan

Background and objective: Patients with locally advanced rectal cancer undergoing preoperative radiotherapy have disparity in pathological tumor regression. This study was to investigate clinicopathologic factors correlated with pathological complete response (pCR) following preoperative radiotherapy in rectal adenocarcinoma.

Methods: In total 132 patients with rectal adenocarcinoma received preoperative radiation from January 2002 to June 2008 at Sun Yat-sen University Cancer Center. Pathological tumor response after radiation was evaluated, and correlations of pCR to 12 clinicopathologic factors were analyzed using logistic regression method.

Results: A total of 18 patients achieved pCR after preoperative radiation, with a pCR rate of 13.6%. Univariate analysis showed that pretreatment T stage with or without concomitant chemotherapy, pretreatment serum CEA level, and CA199 level were correlated with pCR after preoperative radiation in rectal adenocarcinoma. Multivariate analysis revealed that pretreatment serum CEA level and with or without concomitant chemotherapy were independent factors for pCR after radiotherapy in rectal adenocarcinoma.

Conclusion: Patients undergoing preoperative radiochemotherapy with a low pretreatment serum CEA level were more likely to achieve pCR.

背景与目的:局部进展期直肠癌术前放疗患者病理肿瘤消退存在差异。本研究旨在探讨与直肠腺癌术前放疗后病理完全缓解(pCR)相关的临床病理因素。方法:对2002年1月~ 2008年6月中山大学肿瘤中心收治的132例直肠癌患者进行术前放疗。评价放疗后肿瘤病理反应,采用logistic回归方法分析pCR与12个临床病理因素的相关性。结果:术前放疗后,共有18例患者获得pCR, pCR率为13.6%。单因素分析显示,放疗前T期伴或不伴化疗、放疗前血清CEA水平、CA199水平与直肠腺癌术前放疗后pCR相关。多因素分析显示,预处理血清CEA水平和是否合并化疗是直肠癌放疗后pCR的独立影响因素。结论:术前放化疗患者术前血清CEA水平较低更容易实现pCR。
{"title":"[Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma].","authors":"Jun-Zhong Lin,&nbsp;Zhi-Zhong Pan,&nbsp;Zhi-Fan Zeng,&nbsp;Pei-Rong Ding,&nbsp;De-Sen Wan","doi":"10.5732/cjc.008.10808","DOIUrl":"https://doi.org/10.5732/cjc.008.10808","url":null,"abstract":"<p><strong>Background and objective: </strong>Patients with locally advanced rectal cancer undergoing preoperative radiotherapy have disparity in pathological tumor regression. This study was to investigate clinicopathologic factors correlated with pathological complete response (pCR) following preoperative radiotherapy in rectal adenocarcinoma.</p><p><strong>Methods: </strong>In total 132 patients with rectal adenocarcinoma received preoperative radiation from January 2002 to June 2008 at Sun Yat-sen University Cancer Center. Pathological tumor response after radiation was evaluated, and correlations of pCR to 12 clinicopathologic factors were analyzed using logistic regression method.</p><p><strong>Results: </strong>A total of 18 patients achieved pCR after preoperative radiation, with a pCR rate of 13.6%. Univariate analysis showed that pretreatment T stage with or without concomitant chemotherapy, pretreatment serum CEA level, and CA199 level were correlated with pCR after preoperative radiation in rectal adenocarcinoma. Multivariate analysis revealed that pretreatment serum CEA level and with or without concomitant chemotherapy were independent factors for pCR after radiotherapy in rectal adenocarcinoma.</p><p><strong>Conclusion: </strong>Patients undergoing preoperative radiochemotherapy with a low pretreatment serum CEA level were more likely to achieve pCR.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"919-22"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28379588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer]. [survivin和基质金属蛋白酶-7在结肠癌中的表达及临床意义]。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10811
Guo-Qiang Wang, Zhen-Hai Lu, Yu-Jing Fang, Gong Chen, Zhi-Wei Zhou, Zhi-Zhong Pan, De-Sen Wan

Background and objective: Responses and prognosis vary in patients with colon cancer of the same stage using the same therapeutic strategy. Finding a good marker to predict the prognosis is necessary. This study was to explore the correlations of Survivin and matrix metalloproteinase-7 (MMP-7) expression to the prognosis and clinicopathologic features of colon cancer.

Methods: Clinical data of 620 colon cancer patients, treated in Sun Yat-sen University Cancer Center from January 1995 to May 2003, were analyzed. The expression of Survivin and MMP-7 in the 620 specimens of colon cancer was detected by tissue microarray and immunohistochemistry. Correlations of Survivin and MMP-7 expression to the prognosis and clinicopathologic features were analyzed.

Results: The positive rates of survivin and MMP-7 were significantly higher in colon cancer than in normal colon mucosa (41.0% vs. 0, P<0.001; 88.8% vs. 40.9%, P<0.05). There was no relationship between Survivin expression and patients' age, sex, tumor location, gross and histological type, grade, size of colon cancer. The positive rate of Survivin was significantly higher in advanced colon cancer than in early stage colon cancer (P<0.05). There was no relationship between MMP-7 expression and all clinicopathologic factors of colon cancer. Cox untivariate and multivariate regression analyses showed that survivin and MMP-7 expression were independent factors for prognosis of colon cancer.

Conclusion: MMP-7 and survivin are related to the generation of colon cancer, and are independent factors for prognosis of colon cancer.

背景与目的:采用相同治疗策略的同一阶段结肠癌患者的反应和预后各不相同。寻找一个良好的标志物来预测预后是必要的。本研究旨在探讨Survivin和基质金属蛋白酶-7 (matrix metalloproteinase-7, MMP-7)表达与结肠癌预后及临床病理特征的关系。方法:对1995年1月~ 2003年5月中山大学肿瘤中心收治的620例结肠癌患者的临床资料进行分析。采用组织芯片和免疫组化技术检测620例结肠癌组织中Survivin和MMP-7的表达。分析Survivin和MMP-7表达与预后及临床病理特征的相关性。结果:survivin和MMP-7在结肠癌组织中的阳性率明显高于正常结肠黏膜组织(41.0% vs. 0, p)。结论:MMP-7和survivin与结肠癌的发生有关,是影响结肠癌预后的独立因素。
{"title":"[Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer].","authors":"Guo-Qiang Wang,&nbsp;Zhen-Hai Lu,&nbsp;Yu-Jing Fang,&nbsp;Gong Chen,&nbsp;Zhi-Wei Zhou,&nbsp;Zhi-Zhong Pan,&nbsp;De-Sen Wan","doi":"10.5732/cjc.008.10811","DOIUrl":"https://doi.org/10.5732/cjc.008.10811","url":null,"abstract":"<p><strong>Background and objective: </strong>Responses and prognosis vary in patients with colon cancer of the same stage using the same therapeutic strategy. Finding a good marker to predict the prognosis is necessary. This study was to explore the correlations of Survivin and matrix metalloproteinase-7 (MMP-7) expression to the prognosis and clinicopathologic features of colon cancer.</p><p><strong>Methods: </strong>Clinical data of 620 colon cancer patients, treated in Sun Yat-sen University Cancer Center from January 1995 to May 2003, were analyzed. The expression of Survivin and MMP-7 in the 620 specimens of colon cancer was detected by tissue microarray and immunohistochemistry. Correlations of Survivin and MMP-7 expression to the prognosis and clinicopathologic features were analyzed.</p><p><strong>Results: </strong>The positive rates of survivin and MMP-7 were significantly higher in colon cancer than in normal colon mucosa (41.0% vs. 0, P<0.001; 88.8% vs. 40.9%, P<0.05). There was no relationship between Survivin expression and patients' age, sex, tumor location, gross and histological type, grade, size of colon cancer. The positive rate of Survivin was significantly higher in advanced colon cancer than in early stage colon cancer (P<0.05). There was no relationship between MMP-7 expression and all clinicopathologic factors of colon cancer. Cox untivariate and multivariate regression analyses showed that survivin and MMP-7 expression were independent factors for prognosis of colon cancer.</p><p><strong>Conclusion: </strong>MMP-7 and survivin are related to the generation of colon cancer, and are independent factors for prognosis of colon cancer.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"945-9"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28382054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
[Progress and prospects in cancer stem cell research for hepatocellular carcinoma]. [肝癌干细胞研究进展与展望]。
Pub Date : 2009-09-01 DOI: 10.5732/cjc.008.10835
Wen Xu, Lu Cao, Zheng-Feng Yin

The cancer stem cell (CSC) theory stipulates that it is a small population of cells called CSCs that initiates tumor formation and maintains its growth. CSCs are scarce within the bulk of the tumor mass, and possess stem cell-like properties such as self-renewal, differentiation and resistance to therapies, and so on. In the past few years, by using side population technique and approaches based on surface markers, including CD133, CD90, OV6 and EpCAM, researchers have identified and isolated a subpopulation of liver cancer cells with enhanced colony-forming and tumorigenic ability, which is strong evidence for the existence of liver CSCs. In this review, we summarized the progress of research on liver CSCs, discussed the significance of liver CSCs in the diagnosis and treatment of hepatocellular carcinomas, and put forward the future research directions as well as the challenges and opportunities.

癌症干细胞(CSC)理论认为,是少数被称为CSC的细胞群引发肿瘤形成并维持其生长。CSCs在大部分肿瘤中是稀缺的,并且具有干细胞样的特性,如自我更新、分化和对治疗的抵抗等。近年来,研究人员利用基于CD133、CD90、OV6、EpCAM等表面标记物的侧群技术和方法,发现并分离出一种集落形成和致瘤能力增强的肝癌细胞亚群,有力地证明了肝csc的存在。本文综述了肝干细胞的研究进展,讨论了肝干细胞在肝细胞癌诊断和治疗中的意义,并提出了未来的研究方向以及面临的挑战和机遇。
{"title":"[Progress and prospects in cancer stem cell research for hepatocellular carcinoma].","authors":"Wen Xu,&nbsp;Lu Cao,&nbsp;Zheng-Feng Yin","doi":"10.5732/cjc.008.10835","DOIUrl":"https://doi.org/10.5732/cjc.008.10835","url":null,"abstract":"<p><p>The cancer stem cell (CSC) theory stipulates that it is a small population of cells called CSCs that initiates tumor formation and maintains its growth. CSCs are scarce within the bulk of the tumor mass, and possess stem cell-like properties such as self-renewal, differentiation and resistance to therapies, and so on. In the past few years, by using side population technique and approaches based on surface markers, including CD133, CD90, OV6 and EpCAM, researchers have identified and isolated a subpopulation of liver cancer cells with enhanced colony-forming and tumorigenic ability, which is strong evidence for the existence of liver CSCs. In this review, we summarized the progress of research on liver CSCs, discussed the significance of liver CSCs in the diagnosis and treatment of hepatocellular carcinomas, and put forward the future research directions as well as the challenges and opportunities.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"1004-8"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28382602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Measurement and analysis of the imaging dose with megavoltage computed tomography for helical tomotherapy]. 螺旋断层治疗中巨压ct成像剂量的测量与分析。
Pub Date : 2009-08-01 DOI: 10.5732/cjc.008.10632
Shou-Ping Xu, Chuan-Bin Xie, Zhong-Jian Ju, Xiang-Kun Dai, Han-Shun Gong, Yan-Yan Guo, Lian-Yuan Wang

Background & objective: During the helical tomotherapy process, megavoltage computed tomography (MVCT) images are usually used for guiding the precise setup of patients before/after treatment delivery, which would certainly increase the total dose for patients. This study was to investigate the imaging dose of MVCT using the body and head phantom on a tomotherapy machine.

Methods: A set of cylindrical body and head phantoms was adopted for scanning with different pitch values (1.0/2.0/3.0), lengths (4.8/7.2/9.6/12/14.4 cm) and patient setups on the couch of tomotherapy system. The average MVCT imaging doses were measured using A1SL chambers inserted in the phantoms with preset geometry. The dose uniformity was qualitatively analyzed.

Results: The MVCT scanning dose for the body phantom was between 0.599 and 2.876 cGy during each treatment delivery, while the dose for the head phantom was between 0.913 and 3.231 cGy. Two major parameters, the assigned pitch numbers and scanning lengths, were the most important impacts to the dose variation. The MVCT dose was inversely proportional to the CT pitch value. With respect to the scanning length, the doses responded differently along the radial direction of the phantoms with different setup criteria.

Conclusion: The results may provide a reliable guidance for proper planning design of the scanning region, which is valuable to help minimize the extra doses to patient.

背景与目的:在螺旋断层治疗过程中,通常使用MVCT (megavoltage computed tomography, MVCT)图像来指导患者在给药前后的精确设置,这必然会增加患者的总剂量。本研究旨在探讨在断层治疗机上使用身体和头部幻象的MVCT成像剂量。方法:采用一组圆柱形体头模型,在断层治疗系统沙发上进行不同间距值(1.0/2.0/3.0)、长度(4.8/7.2/9.6/12/14.4 cm)和患者设置的扫描。平均MVCT成像剂量测量使用A1SL室插入具有预设几何形状的幻影。定量分析了剂量均匀性。结果:每次给药期间,体影MVCT扫描剂量在0.599 ~ 2.876 cGy之间,头影MVCT扫描剂量在0.913 ~ 3.231 cGy之间。两个主要参数,即指定的基音数和扫描长度,是对剂量变化最重要的影响。MVCT剂量与CT节距值成反比。相对于扫描长度,不同设置标准下,剂量沿着幽灵的径向响应不同。结论:该结果可为合理规划设计扫描区域提供可靠的指导,有助于减少患者的额外剂量。
{"title":"[Measurement and analysis of the imaging dose with megavoltage computed tomography for helical tomotherapy].","authors":"Shou-Ping Xu,&nbsp;Chuan-Bin Xie,&nbsp;Zhong-Jian Ju,&nbsp;Xiang-Kun Dai,&nbsp;Han-Shun Gong,&nbsp;Yan-Yan Guo,&nbsp;Lian-Yuan Wang","doi":"10.5732/cjc.008.10632","DOIUrl":"https://doi.org/10.5732/cjc.008.10632","url":null,"abstract":"<p><strong>Background & objective: </strong>During the helical tomotherapy process, megavoltage computed tomography (MVCT) images are usually used for guiding the precise setup of patients before/after treatment delivery, which would certainly increase the total dose for patients. This study was to investigate the imaging dose of MVCT using the body and head phantom on a tomotherapy machine.</p><p><strong>Methods: </strong>A set of cylindrical body and head phantoms was adopted for scanning with different pitch values (1.0/2.0/3.0), lengths (4.8/7.2/9.6/12/14.4 cm) and patient setups on the couch of tomotherapy system. The average MVCT imaging doses were measured using A1SL chambers inserted in the phantoms with preset geometry. The dose uniformity was qualitatively analyzed.</p><p><strong>Results: </strong>The MVCT scanning dose for the body phantom was between 0.599 and 2.876 cGy during each treatment delivery, while the dose for the head phantom was between 0.913 and 3.231 cGy. Two major parameters, the assigned pitch numbers and scanning lengths, were the most important impacts to the dose variation. The MVCT dose was inversely proportional to the CT pitch value. With respect to the scanning length, the doses responded differently along the radial direction of the phantoms with different setup criteria.</p><p><strong>Conclusion: </strong>The results may provide a reliable guidance for proper planning design of the scanning region, which is valuable to help minimize the extra doses to patient.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":" ","pages":"886-9"},"PeriodicalIF":0.0,"publicationDate":"2009-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40020017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Ai zheng = Aizheng = Chinese journal of cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1